Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the company to lose more than 40% of their value in pre-market trading. The news is ...
Biogen has started a phase 3 trial that it hopes will extend the label for its Skyclarys therapy for inherited neurological disease Friedreich's ataxia (FA) to include children as young as two.
Arising from: Pulst SM (2007) Ataxia rating scales in the balance. Nat Clin Pract Neurol 3: 119 doi:10.1038/ncpneuro0446 Subramony SH (2007) SARA—a new clinical ...
A Novel Mouse Model of Ataxia Telangiectasia for Testing Small Molecule Readthrough (SMRT) Compounds
Investigator & Co-Director of the Neurotherapeutics IWI, Lundquist Institute (Formerly "LA BioMed"); Assistant Professor, David Geffen School of Medicine at UCLA Department of Neurology Ataxia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback